View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
DREAMM-7 - Belantamab-Mafodotin 2,5 / Bortezomib 1,3 / Dexamethason 20 - Belantamab-Mafodotin 2,5, multiples Myelom, Zyklus 9+
Protocol-ID: 3175 V1.0 (Mini), DREAMM-7 - BELMAF2,5/BORT1,3/DEXA20 - BELMAF2,5, MM, Z9+Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 26.03.2026